Clear Search sequence regions


  • 4 and (1)
  • across (3)
  • AD1 (4)
  • AD2 (4)
  • alveolar soft part sarcoma (3)
  • BCL2 (9)
  • blue (1)
  • BMP2 (1)
  • bone (1)
  • cancer (4)
  • cancer gene (1)
  • cases (1)
  • CBP p300 (2)
  • CCND1 (10)
  • cdna (3)
  • cell cycle (6)
  • cell numbers (3)
  • cellular (2)
  • china (1)
  • chondroblasts (2)
  • chondrosarcomas (36)
  • chromatin (16)
  • CID (4)
  • cohort (1)
  • contains (2)
  • corepressors (1)
  • culture cell (1)
  • cytoplasm (1)
  • data analysis (4)
  • data file (8)
  • desmoplastic small round cell tumor (3)
  • diagnosis (1)
  • dimer (1)
  • direct (15)
  • disease and (1)
  • dna sequences (1)
  • ds dna (2)
  • dye (1)
  • e box motif (4)
  • e box sequences (5)
  • edu (5)
  • EGFP (6)
  • elements (1)
  • ewing sarcoma (3)
  • ews sarcoma (1)
  • exon (11)
  • expressed genes (2)
  • factor (1)
  • FGF (2)
  • fibroblast growth factor (1)
  • fibrosarcoma (5)
  • flow (3)
  • FOXC1 (1)
  • fusion cell (2)
  • GAPDH (2)
  • GAPDH 1 (1)
  • gastrointestinal stromal tumor (3)
  • gene fusion (3)
  • gene fusions (1)
  • genes (38)
  • growth factors (2)
  • hedgehog (1)
  • help (2)
  • HES1 (9)
  • HEY1 (325)
  • hey1– proteins (25)
  • horseradish (1)
  • human (5)
  • human cell (2)
  • igf (1)
  • igf 1 (1)
  • immunoblot (1)
  • insulin like growth factor (1)
  • ipsc‐ derived mesenchymal stem cells (27)
  • ireland (2)
  • KLF10 (1)
  • laemmli buffer (1)
  • lentivirus (2)
  • ligand (1)
  • MEF2C (1)
  • model molecular (1)
  • mrna (2)
  • mTOR (1)
  • NCOA2 (270)
  • neoplasia (1)
  • NES (3)
  • new england (1)
  • nuclear receptor (4)
  • osteosarcoma (1)
  • PAS (2)
  • pathogenesis (1)
  • patient (6)
  • pcr (3)
  • PDGF (6)
  • pdgf receptor (2)
  • PDGFB (8)
  • PDGFR (3)
  • PDGFRA (8)
  • pdgfrb (1)
  • penicillin (1)
  • phase (2)
  • PI3K (5)
  • picogreen (2)
  • PKC α (1)
  • plasmids (2)
  • profiles (3)
  • protein binds (3)
  • protein c (1)
  • protein family (1)
  • protein level (1)
  • protocol (3)
  • rabbit (4)
  • reagents (2)
  • Real‐ time (10)
  • repress (1)
  • retinoid (1)
  • rhabdomyosarcoma (3)
  • rna (36)
  • RNase (1)
  • RTR2 (1)
  • sarcoma (6)
  • seq (23)
  • sequenced dna (1)
  • serum (1)
  • signal (2)
  • skeletogenic progenitor‐ stem cells (3)
  • slide (1)
  • SOX11 (2)
  • SOX12 (2)
  • SOX4 (8)
  • spheroids (2)
  • SRCs (1)
  • stem cells (6)
  • steroid (1)
  • streptomycin (1)
  • synovial sarcoma (3)
  • target genes (11)
  • thyroid (1)
  • tween 20 (1)
  • VEGF (1)
  • vitamin d receptors (1)
  • WNT (1)
  • WNT10B (1)
  • WNT7A (1)
  • young adults (1)
  • Sizes of these terms reflect their relevance to your search.

    Mesenchymal chondrosarcoma is a rare, high-grade, primitive mesenchymal tumor. It accounts for around 2-10% of all chondrosarcomas and mainly affects adolescents and young adults. We previously described the HEY1-NCOA2 as a recurrent gene fusion in mesenchymal chondrosarcoma, an important breakthrough for characterizing this disease; however, little study had been done to characterize the fusion protein functionally, in large part due to a lack of suitable models for evaluating the impact of HEY1-NCOA2 expression in the appropriate cellular context. We used iPSC-derived mesenchymal stem cells (iPSC-MSCs), which can differentiate into chondrocytes, and generated stable transduced iPSC-MSCs with inducible expression of HEY1-NCOA2 fusion protein, wildtype HEY1 or wildtype NCOA2. We next comprehensively analyzed both the DNA binding properties and transcriptional impact of HEY1-NCOA2 expression by integrating genome-wide chromatin immunoprecipitation sequencing (ChIP-seq) and expression profiling (RNA-seq). We demonstrated that HEY1-NCOA2 fusion protein preferentially binds to promoter regions of canonical HEY1 targets, resulting in transactivation of HEY1 targets, and significantly enhances cell proliferation. Intriguingly, we identified that both PDGFB and PDGFRA were directly targeted and upregulated by HEY1-NCOA2; and the fusion protein, but not wildtype HEY1 or NCOA2, dramatically increased the level of phospho-AKT (Ser473). Our findings provide a rationale for exploring PDGF/PI3K/AKT inhibition in treating mesenchymal chondrosarcoma. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

    Citation

    Wenqing Qi, Wojciech Rosikiewicz, Zhaohong Yin, Beisi Xu, Huihong Jiang, Shibiao Wan, Yiping Fan, Gang Wu, Lu Wang. Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis. The Journal of pathology. 2022 Apr 26;257(5):579-592

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35342947

    View Full Text